July 02, 2025

Body Fat Percentage Outranks BMI for Mortality

New research shows body fat percentage predicts long-term mortality more accurately than BMI, suggesting a need to revise how body composition is measured in clinical care.

Conexiant

June 30, 2025

Breakthrough Device Approvals Outpacing Data

Many FDA-authorized breakthrough therapeutic devices may lack robust clinical testing.

Conexiant

June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

June 24, 2025

Cannabis Use Linked to Higher Heart Risks

A new systematic review and meta-analysis found that cannabis use is associated with an increased risk of major adverse cardiovascular events—including acute coronary syndrome, stroke, and cardiovascular death—based on data from more than 432 million individuals in 24 observational studies.

Conexiant

June 23, 2025

Sitting-Rising Test Predicts Long-Term Mortality Risk

A 12-year study of over 4,000 adults found that poor performance on a basic sitting and rising test was strongly linked to increased risk of death from natural and cardiovascular causes.

Conexiant

June 23, 2025

Psoriasis Biologics May Reduce Heart Risks

A large international study found that psoriasis patients treated with biologic therapies had a significantly lower risk of cardiovascular disease compared to those receiving oral treatments.

Conexiant

June 21, 2025

New Science Cardiovascular Supplement + Podcast with Mount Sinai Drs. Bhatt and Swirski

Cardiovascular disease remains a dominant global health burden, rooted in complex molecular and cellular pathobiology that evolves across an individual’s lifespan. Yet advances at the intersection of biomedical research and technology are revolutionizing how we understand, detect, and treat these complex conditions. Innovations in artificial intelligence, precision genomics, and advanced cardiac imaging now enable earlier, more accurate risk stratification, highly individualized therapeutic strategies, and deeper mechanistic insights, including the pivotal role of inflammation in atherogenesis and disease progression.

Mount Sinai New York

June 20, 2025

Gut Bacteria Predict Chemotherapy-Related Heart Damage

Specific gut bacteria correlate with biomarkers indicating increased risk of cardiotoxicity in breast cancer patients before chemotherapy treatment.

Conexiant